GlassScriptPhysician profile
James Reece Harris
NPI 1760002034
$1,427.86
in general payments reported to CMS, 2019-2025
13 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $274 · 2024: $565 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $198.37 | 2023-2025 | Floseal |
| Kerecis Limited | $183.79 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Acera Surgical, INC. | $140.38 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $126.36 | 2025 | Sternalock Blu System |
| Davol INC. | $117.65 | 2024 | Phasix Mesh |
| Teleflex LLC | $113.62 | 2025 | Titan Sgs Bailout Chuck |
| Conmed Corporation | $104.58 | 2025 | Airseal |
| Intuitive Surgical, INC. | $97.82 | 2024 | |
| Innovation Technologies INC | $88.75 | 2024 | Irrisept |
| Ethicon US, LLC | $87.20 | 2023 | Stratafix, Surgicel Nu-Knit |
| Medtronic, INC. | $78.41 | 2023 | Signia |
| Solventum Corporation | $77.27 | 2024 | Prevena, V.A.C.Ulta |
| Lemaitre Vascular, INC. | $13.66 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.